An open comparative trial of three doses of ciramadol used intravenously in renal colic.
In an open investigation, ciramadol, a partial agonist opioid, was found to be a potent analgesic when given intravenously in patients experiencing renal colic. Single intravenous doses of 20, 30 and 40 mg of ciramadol were given to 11, 11 and 12 patients with renal colic, respectively, and good pain relief was obtained in 10, 11 and 10 patients, respectively. Vomiting and nausea occurred in 9 patients, 4 in the 20 mg group, 2 in the 30 mg group and 3 in the 40 mg group. This adverse effect was related to standing and walking following the ciramadol injection.
D000328:Adult; D000588:Amines / Q000008:administration & dosage*; D000700:Analgesics / Q000008:administration & dosage; D001596:Benzylamines / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003085:Colic / Q000188:drug therapy*; D004244:Dizziness / Q000139:chemically induced; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D007674:Kidney Diseases / Q000188:drug therapy*; D008297:Male; D010146:Pain / Q000188:drug therapy
D000588:Amines; D000700:Analgesics; D001596:Benzylamines; C018273:ciramadol